Status:
UNKNOWN
Identification of Vulnerability Factors in the Course of Pemphigus Patients
Lead Sponsor:
University Hospital, Rouen
Conditions:
Pemphigus
Dermatological Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The bullous pemphigoid treatment is based on corticosteroids continued for several years. Pemphigus causes some patients a psychological impact and sometimes major vulnerability that can occur not onl...
Detailed Description
The originality of the project lies in its multidisciplinary approach (dermatology, psychology, sociology). No such study has yet been carried out in the pemphigus who has been the subject of a very s...
Eligibility Criteria
Inclusion
- Patient major
- Patients with pemphigus vulgaris, diagnosed on a combination of:
- clinical signs and
- histological image above basal epithelial detachment with intra acantholysis,
- direct immunofluorescence showing deposition of Immunoglobulin G and / or C3 to the surface of keratinocytes
- Join a social security scheme
- patient has been informed and have signed consent to participate in the study
Exclusion
- Person placed under judicial protection,
- Patient without liberty by administrative or judicial decision,
- Patient participating in another trial for the duration of monitoring.
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02237313
Start Date
July 1 2015
End Date
November 1 2018
Last Update
August 30 2017
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Avicenne
Bobigny, France, 93000
2
CHU de Clermont-Ferrand Hôpital d'Estaing
Clermont-Ferrand, France, 63003
3
CH du Mans
Le Mans, France, 72037
4
CHRU de Lille Hôpital Claude Huriez
Lille, France, 59037